Albert Bourla is a Greek-American veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer’s divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.

In addition to the boards of Pfizer and the Pfizer Foundation, he serves or has served on the boards of the Biotechnology Innovation Organization, Catalyst, the Partnership for New York City, and the Pharmaceutical Research and Manufacturers of America. Bourla is also a member of The Business Council and the Business Roundtable

Albert Bourla Net Worth

The estimated Net Worth of Albert Bourla is at least $34.5 Million dollars as of 17 December 2021. Albert Bourla owns over 123,055 units of Pfizer stock worth over $11,035,762 and over the last 9 years, he sold PFE stock worth over $5,557,386. In addition, he makes $17,929,000 as Chairman of the Board and Chief Executive Officer at Pfizer.

ncG1vNJzZmivp6x7u7PRZ6WerF%2Bau3DDyKSgaJmcl7KzwIybpq6qnJZ6r7HTZq6oqqSdfA%3D%3D